Progeroid syndrome as a model for impaired bone formation in senile osteoporosis

Author(s):  
Akinori Hishiya ◽  
Ken Watanabe
1973 ◽  
Vol 1 (6) ◽  
pp. 509-529 ◽  
Author(s):  
K Little

Osteogenic cells are derived from sinusoid vessel walls. When conditions are favourable—a supply of energy, correct concentrations of oxygen and carbon dioxide, the hormone balance on the anabolic and anticatabolic side, the osteogenic factor present—osteogenic precursor cells differentiate to osteoblasts and osteocytes. When the balance is on the catabolic side precursor cells coalesce to form osteoclasts. When catabolic conditions persist osteoclastic activity continues until all the precursor cells are used up. Phagocytic cells can also enlarge and coalesce to form osteoclasts. Parathyroid hormone is needed for coalescence. The formation of these osteoclasts is stimulated by an increased marrow pressure or exposure of dead bone tissue. Corticosteroids prevent initial enlargement of cells. Excess parathyroid hormone stimulates the production and activity of extra phagocytic osteoclasts. The hormone balance may approach the catabolic during later stages of pregnancy and after childbirth, after the menopause, during and after the general hormonal decline in old age, when corticosteroids are given for therapeutic purposes, or as a result of the action of contraceptive agents. The effects of stress (caused by the unpleasant emotions, fear, apprehension frustration, jealousy, anxiety, etc, as well as serious illness or trauma) include a rise in blood cortisol levels. A combination of factors may result in corticosteroid levels exceeding the threshold for thrombus formation. This threshold depends on the other chemicals affecting the pituitary-adrenal system that are present. It is abnormally low for contraceptive agents. These mechanisms of bone formation and removal account for the main types of osteoporosis. A lowered blood flow arises from a decrease or cessation of muscle activity, the effect of catabolic compounds on muscle fibres, or thrombi lodged in vessels supplying muscles and bone. A build-up of pressure stimulates the formation of phagocytic osteoclasts, while until the flow is increased again there is insufficient stimulus for new bone formation. When catabolic conditions prevail, osteogenic precursor cells coalesce to osteoclasts, and when anticatabolic conditions return, more precursor cells are formed that may proceed to osteoblast and bone formation before the next catabolic episode. With an unfortunate timing of alternations this results in considerable bone loss. In pregnancy the loss is temporary, but after the menopause and in old age there may be a permanent decrease of bone tissue. This type of osteoporosis may also be caused by contraceptive agents. It leads to backache, the increased number of fractured wrists in older women, and intracapsular hip fractures. Small thrombi cause irreversible osteoporosis. Blood flow through bone is decreased, and vessels in cortical bone blocked. Bone served by these vessels dies, and with prolonged catabolic conditions a considerable amount of dead bone tissue may be present. After phagocytic removal it is not usually replaced. This type of ‘senile’ osteoporosis, which can cause extracapsular hip fractures, is common in old age. It is also the main mechanism of osetoporosis caused by contraceptive agents. There are racial variations. Negroes are the least susceptible and the Japanese the most susceptible. In elderly people senile osteoporosis is part of a more generalized condition. The liver and brain are also affected—there are considerable individual variations, but symptoms often include depression and sometimes pyschotic episodes. Like diabetes and thyroid deficiency, an anticatabolic deficiency requires continuous therapy. The anticatabolic agent chosen should be one that reverses corticosteroid effects on bone, liver and brain efficiently, and at the same time has a high Cortisol threshold for thrombus formation.


2018 ◽  
Vol 5 (4) ◽  
pp. 21-25
Author(s):  
Pedro Sánchez Márquez ◽  
Carlos Arturo Révérend Lizcano

El presente artículo tiene como objetivo presentar de forma resumida los diferentes factores que están involucrados en la diferenciación y el mantenimiento del fenotipo óseo, en contraste con los factores adipogénicos, cuya expresión determina procesos de diferenciación mutuamente excluyentes. Por otro lado, se propone el posible uso terapéutico para distintas patologías óseas como la osteoporosis. Los datos fueron obtenidos de estudios clínicos aleatorizados y de revisión, en idioma español e inglés, de los últimos 15 años, que incluyeran los términos Mesh: Osteoporosis; Osteoporoses; Osteoporosis, Post-Traumatic; Osteoporosis, Senile; Osteoporosis, Age-Related; Bone Loss, Age-Related; Factors, Transcription; Transcription Factor; Adipogeneses; Bone Formation; Osteoclastogenesis; Endochondral Ossification; Endochondral Ossifications; Ossification, Endochondral; Ossification, Physiological; Ossification, Physiologic.


2005 ◽  
Vol 288 (4) ◽  
pp. E723-E730 ◽  
Author(s):  
Gustavo Duque ◽  
Michael Macoritto ◽  
Natalie Dion ◽  
Louis-Georges Ste-Marie ◽  
Richard Kremer

Recent studies suggest that vitamin D signaling regulates bone formation. However, the overall effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on bone turnover in vivo is still unclear. In this study, our aim was to examine the effect of 1,25(OH)2D3 on bone turnover in SAM-P/6, a hormone-independent mouse model of senile osteoporosis characterized by a decrease in bone formation. Male and female 4-mo-old SAM-P/6 mice were treated with 1,25(OH)2D3 (18 pmol/24 h) or vehicle for a period of 6 wk, and a group of age- and sex-matched nonosteoporotic animals was used as control. Bone mineral density (BMD) at the lumbar spine increased rapidly by >30 ± 5% ( P < 0.001) in 1,25(OH)2D3-treated SAM-P/6 animals, whereas BMD decreased significantly by 18 ± 2% ( P < 0.01) in vehicle-treated SAM-P/6 animals and remained stable in control animals during the same period. Static and dynamic bone histomorphometry indicated that 1,25(OH)2D3 significantly increased bone volume and other parameters of bone quality as well as subperiosteal bone formation rate compared with vehicle-treated SAM-P/6 mice. However, no effect on trabecular bone formation was observed. This was accompanied by a marked decrease in the number of osteoclasts and eroded surfaces. A significant increase in circulating bone formation markers and a decrease in bone resorption markers was also observed. Finally, bone marrow cells, obtained from 1,25(OH)2D3-treated animals and cultured in the absence of 1,25(OH)2D3, differentiated more intensely into osteoblasts compared with those derived from vehicle-treated mice cultured in the same conditions. Taken together, these findings demonstrate that 1,25(OH)2D3 acts simultaneously on bone formation and resorption to prevent the development of senile osteoporosis.


2013 ◽  
Vol 22 (4) ◽  
pp. 461-472 ◽  
Author(s):  
Ryuichi Ogasawara ◽  
Yoshitaka Furuya ◽  
Hodaka Sasaki ◽  
Masao Yoshinari ◽  
Yasutomo Yajima

2017 ◽  
Vol 49 ◽  
pp. 42-52 ◽  
Author(s):  
Lucia Dwi Antika ◽  
Eun-Jung Lee ◽  
Yun-Ho Kim ◽  
Min-Kyung Kang ◽  
Sin-Hye Park ◽  
...  

2020 ◽  
Author(s):  
Yizhong Bao ◽  
Xiaoling Lv ◽  
Ying Tang ◽  
Xuanliang Ru ◽  
Jirong Wang ◽  
...  

Abstract Background Lithium chloride (LiCl) is commonly used in the clinic for the treatment of bipolar and other mental disorders. LiCl is an inhibitor of GSK-3β, and has been reported to modulate the balance of adipogenesis and osteogenesis. But, whether LiCl impacts bone formation and homeostasis in senile osteoporosis is still unclear. Methods Analysis of tibia in 2, 5, 7 and 10 months old C57BL/6 male mice were performed by MicroCT (μCT). 7 months old wild-type mice were treated with LiCl orally 0, 100 or 200 mg/kg for 3 months and then tested by μCT. The levels of osteogenesis marker genes and Wnt signaling target genes in bone marrow stromal cells (BMSCs) were detected by reverse transcription quantitative polymerase chain reaction and immunostaining. BMSCs were induced osteoblast differentiation and tested by Alizarin red S staining. Results μCT analyses of C57BL/6 mice showed that bone mineral density (BMD) and trabecular thickness (Tb.Th) increased until the bone mass peaked (5 months) and then began to fall subsequently. LiCl dramatically enhanced bone mass in the senile osteoporotic conditions, represented by increased ratio of bone volume to tissue volume (BV/TV), and decreased in trabeculae separation (Tb.Sp). Moreover, LiCl significantly increased both canonical osteoblastogenesis and Wnt signaling activity without affecting hormones. Conclusion This study uncovered the role of LiCl in canonical Wnt signaling and bone formation and have provided the evidence that LiCl may potentially repress senile osteoporosis.


2006 ◽  
Vol 76 (3) ◽  
pp. 111-116 ◽  
Author(s):  
Hiroshi Matsuzaki ◽  
Misao Miwa

The purpose of this study was to clarify the effects of dietary calcium (Ca) supplementation on bone metabolism of magnesium (Mg)-deficient rats. Male Wistar rats were randomized by weight into three groups, and fed a control diet (control group), a Mg-deficient diet (Mg- group) or a Mg-deficient diet having twice the control Ca concentrations (Mg-2Ca group) for 14 days. Trabecular bone volume was significantly lower in the Mg - and Mg-2Ca groups than in the control group. Trabecular number was also significantly lower in the Mg - and Mg-2Ca groups than in the control group. Mineralizing bone surface, mineral apposition rate (MAR), and surface referent bone formation rate (BFR/BS) were significantly lower in the Mg - and Mg-2Ca groups than in the control group. Furthermore, MAR and BFR/BS were significantly lower in the Mg-2Ca group than in the Mg - group. These results suggest that dietary Ca supplementation suppresses bone formation in Mg-deficient rats.


Sign in / Sign up

Export Citation Format

Share Document